Osiris Therapeutics Inc. (NASDAQ:OSIR) fell 2.2% during mid-day trading on Wednesday . The stock traded as low as $4.67 and last traded at $4.86, with a volume of 61,457 shares traded. The stock had previously closed at $4.97.

The firm has a market capitalization of $168.47 million, a P/E ratio of 116.43 and a beta of 0.53. The stock has a 50 day moving average of $5.23 and a 200-day moving average of $5.30.

Several institutional investors have recently bought and sold shares of the stock. Rhumbline Advisers raised its position in Osiris Therapeutics by 0.5% in the second quarter. Rhumbline Advisers now owns 19,569 shares of the company’s stock valued at $100,000 after buying an additional 95 shares during the period. ProShare Advisors LLC raised its position in Osiris Therapeutics by 1.6% in the second quarter. ProShare Advisors LLC now owns 28,080 shares of the company’s stock valued at $143,000 after buying an additional 434 shares during the period. Schwab Charles Investment Management Inc. raised its position in Osiris Therapeutics by 1.4% in the second quarter. Schwab Charles Investment Management Inc. now owns 53,481 shares of the company’s stock valued at $273,000 after buying an additional 756 shares during the period. California State Teachers Retirement System raised its position in Osiris Therapeutics by 3.2% in the second quarter. California State Teachers Retirement System now owns 41,684 shares of the company’s stock valued at $212,000 after buying an additional 1,276 shares during the period. Finally, Alliancebernstein L.P. raised its position in Osiris Therapeutics by 7.4% in the second quarter. Alliancebernstein L.P. now owns 40,692 shares of the company’s stock valued at $207,000 after buying an additional 2,800 shares during the period. Institutional investors own 20.67% of the company’s stock.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/osiris-therapeutics-inc-osir-shares-down-2-2.html

Osiris Therapeutics Company Profile

Osiris Therapeutics, Inc is a medical products company. The Company is focused on developing and marketing products in regenerative medicine, including bioengineering, stem cell research and viable tissue based products. The Company’s offers products in orthopedics, sports medicine and wound care, including Cartiform, BIO4 and Grafix.

5 Day Chart for NASDAQ:OSIR

Receive News & Ratings for Osiris Therapeutics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Osiris Therapeutics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.